Abstract
Background. Cerebrospinal fluid (CSF) cryptococcal glucuronoxylomannan antigen (CrAg) titers generally correlate with quantitative fungal culture burden; however, correlation is not precise. Some patients have higher CrAg titers with lower fungal burdens and vice versa. We hypothesized that the relative discordancy between CrAg titer and quantitative culture burden reflects the relative degree of CrAg shedding by Cryptococcus neoformans and is associated with human immune responses. Methods. One hundred ninety human immunodeficiency virus-infected individuals with cryptococcal meningitis were enrolled in Uganda and South Africa. We compared initial CSF CrAg titers relative to their CSF quantitative cultures to determine low (n = 58), intermediate (n = 68), or high (n = 64) CrAg shedders. We compared cytokines measured by Luminex multiplex assay on cryopreserved CSF and 10-week mortality across shedding groups using linear and logistic regression and distribution of genotypes by multilocus sequence typing. Results. The relative degree of CrAg shedding was positively associated with increasing CSF levels of the following: interleukin (IL)-6, IL-7, IL-8, and tumor necrosis factor-α (each P < 0.01), which are all secreted by ant...Continue Reading
References
Jul 15, 1999·Clinical and Experimental Immunology·K KawakamiA Saito
Aug 26, 1999·Applied Occupational and Environmental Hygiene
Dec 3, 2005·Genetics·Anastasia P LitvintsevaThomas G Mitchell
Jun 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tihana BicanicThomas Harrison
Jan 17, 2009·The American Journal of Pathology·Werner StenzelGottfried Alber
Feb 3, 2009·AIDS·Benjamin J ParkTom M Chiller
May 12, 2009·Advances in Applied Microbiology·Oscar ZaragozaArturo Casadevall
May 23, 2009·Medical Mycology·Wieland MeyerJune Kwon-Chung
Aug 4, 2010·The Journal of Infectious Diseases·David R BoulwarePaul R Bohjanen
Jan 22, 2011·PLoS Medicine·David R BoulwarePaul R Bohjanen
Sep 17, 2011·Frontiers in Microbiology·Oscar Zaragoza
Mar 17, 2012·AIDS·Joseph N JarvisThomas S Harrison
Sep 28, 2012·MBio·Darin L WiesnerKirsten Nielsen
Dec 20, 2012·PloS One·Elissa K ButlerDavid B Meya
Mar 8, 2013·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kara N DurskiDavid R Boulware
Mar 26, 2013·AIDS·Christina C ChangMartyn A French
Jun 15, 2013·The Journal of Infectious Diseases·Christina C ChangMartyn A French
Aug 16, 2013·The Journal of Infectious Diseases·Emma J RobertsonTihana Bicanic
Sep 26, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Taseera KabandaDavid R Boulware
Dec 10, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph N JarvisThomas Harrison
Jan 1, 2014·Emerging Infectious Diseases·David R BoulwareDavid B Meya
Jun 26, 2014·The New England Journal of Medicine·David R BoulwareUNKNOWN COAT Trial Team
Mar 13, 2015·PLoS Pathogens·Darin L WiesnerKirsten Nielsen
Apr 9, 2015·PLoS Pathogens·Joseph N JarvisThomas S Harrison
Citations
Aug 16, 2016·Case Reports in Neurological Medicine·Kedar R MahajanLori Sheehan
Nov 20, 2016·Yeast·Aleeza C Gerstein, Kirsten Nielsen
May 10, 2017·PloS One·Delio José MoraMario León Silva-Vergara
Dec 6, 2017·Infection and Immunity·Steven T DenhamJessica C S Brown
Oct 27, 2018·HIV Medicine·A Balasko, Y Keynan
Mar 6, 2019·Infection and Immunity·Liliane MukaremeraKirsten Nielsen
Oct 28, 2016·Nature Reviews. Neurology·Lauren N BowenAvindra Nath
Feb 2, 2017·MBio·Felipe H Santiago-TiradoTamara L Doering
Jul 25, 2018·Open Forum Infectious Diseases·Irina Vlasova-St LouisPaul R Bohjanen
May 22, 2021·Infectious Disease Clinics of North America·Alexis C GushikenJohn W Baddley
Jul 7, 2021·Medical Microbiology and Immunology·Aline Beatriz Mahler PereiraAlexandre Paula Rogerio
Aug 19, 2021·Inflammopharmacology·Bruno Sada SalernoAlexandre Paula Rogerio